Capital expenditure increased 45.7%
Capital expenditure changed +45.7% from the comparable as-filed period.
$3.5M→$5.1M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TCX financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 200.6%
Free-cash-flow proxy changed -200.6% from the comparable as-filed period.
$3.1M→-$3.1M3 prior comparisons
Net income decreased 30.9%
Net income changed -30.9% from the comparable as-filed period.
-$15.6M→-$20.5M3 prior comparisons
Operating cash flow decreased 70.5%
Operating cash flow changed -70.5% from the comparable as-filed period.
$6.6M→$1.9M3 prior comparisons
Operating income decreased 89.5%
Operating income changed -89.5% from the comparable as-filed period.
-$2.9M→-$5.5M3 prior comparisons
Research & development increased 11.9%
Research & development changed +11.9% from the comparable as-filed period.
$4.3M→$4.9M3 prior comparisons
Cash & equivalents decreased 15.1%
Cash & equivalents changed -15.1% from the comparable as-filed period.
$52.0M→$44.2M2 prior comparisons
Gross profit increased 16.6%
Gross profit changed +16.6% from the comparable as-filed period.
$22.1M→$25.8M3 prior comparisons
Inventory increased 15.2%
Inventory changed +15.2% from the comparable as-filed period.
$3.4M→$4.0M3 prior comparisons
Stock-based compensation decreased 16.0%
Stock-based compensation changed -16.0% from the comparable as-filed period.
$1.4M→$1.2M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.